Document is current

Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases

Crossref DOI link: https://doi.org/10.1186/s12969-016-0112-6

Published Online: 2016-09-13

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy